KR20140011383A - 치환된 디페닐 유도체 - Google Patents

치환된 디페닐 유도체 Download PDF

Info

Publication number
KR20140011383A
KR20140011383A KR1020137027073A KR20137027073A KR20140011383A KR 20140011383 A KR20140011383 A KR 20140011383A KR 1020137027073 A KR1020137027073 A KR 1020137027073A KR 20137027073 A KR20137027073 A KR 20137027073A KR 20140011383 A KR20140011383 A KR 20140011383A
Authority
KR
South Korea
Prior art keywords
alkyl
group
ethyl
hydrogen
solvates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020137027073A
Other languages
English (en)
Korean (ko)
Inventor
헤인쯔 포스터
Original Assignee
크리에이티브 테라퓨틱스 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크리에이티브 테라퓨틱스 게엠베하 filed Critical 크리에이티브 테라퓨틱스 게엠베하
Publication of KR20140011383A publication Critical patent/KR20140011383A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63Esters of sulfonic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00Esters of sulfuric acids
    • C07C305/22Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C307/00Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C307/02Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C317/34Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/46Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
    • C07C323/48Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/382,3-Dihydro derivatives, e.g. isoflavanones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1020137027073A 2011-03-16 2012-03-12 치환된 디페닐 유도체 Ceased KR20140011383A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102011014087 2011-03-16
DE102011014087.5 2011-03-16
PCT/DE2012/000258 WO2012122969A1 (de) 2011-03-16 2012-03-12 Substituierte diphenylderivate

Publications (1)

Publication Number Publication Date
KR20140011383A true KR20140011383A (ko) 2014-01-28

Family

ID=46201039

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137027073A Ceased KR20140011383A (ko) 2011-03-16 2012-03-12 치환된 디페닐 유도체

Country Status (15)

Country Link
US (1) US9409859B2 (enExample)
EP (1) EP2686298B1 (enExample)
JP (1) JP2014515734A (enExample)
KR (1) KR20140011383A (enExample)
CN (1) CN103492365A (enExample)
AU (1) AU2012228755B2 (enExample)
BR (1) BR112013023316B1 (enExample)
CA (1) CA2829998C (enExample)
EA (1) EA024381B1 (enExample)
ES (1) ES2683306T3 (enExample)
IL (1) IL228431A (enExample)
MX (1) MX346097B (enExample)
SG (1) SG193443A1 (enExample)
WO (1) WO2012122969A1 (enExample)
ZA (1) ZA201306794B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102015008631A1 (de) 2014-10-30 2016-05-04 Creative Therapeutics Gmbh Arzneimittel für die Krebstherapie
CN109293661A (zh) * 2018-10-22 2019-02-01 武汉华星光电半导体显示技术有限公司 近红外光热激活延迟荧光材料及其制备方法、显示装置
DE102020125641A1 (de) 2020-09-25 2022-03-31 Creative Therapeutics Gmbh Wirkstoffe und Arzneimittel für die Therapie von Viruserkrankungen, insbesondere Corona-Infektionen, insbesondere COVID-19
CN115582027B (zh) * 2022-09-09 2024-07-19 天津工业大学 一种不同长度烷基链修饰的共价有机框架有机溶剂纳滤膜制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2648660A (en) 1953-08-11 Process fob
GB691410A (en) * 1950-03-25 1953-05-13 Cfmc Process for the preparation of diazoamino compounds and water-insoluble azodyestuffs on fibres
DE1793115A1 (de) * 1968-08-03 1972-02-03 Bayer Ag Neue Triazenderivate
BE789138A (fr) 1971-09-24 1973-03-22 Bayer Ag Nouveaux derives triazeniques, leur procede de preparation et medicament les contenant
DE4334823C2 (de) 1993-10-09 1998-09-17 Schering Ag Verfahren zur Herstellung von Schwefelsäurehalbestern von Estrogenen
DE10052333A1 (de) 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
DE10324496A1 (de) 2003-05-30 2004-12-16 Bayer Healthcare Ag Targetorientierte Chemotherapie von Tumoren der Sexualorgane
ME01058B (me) 2004-07-28 2012-10-20 Janssen Pharmaceutica Nv Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
AU2007271486A1 (en) 2006-07-05 2008-01-10 Merck Patent Gmbh Sulfamate benzothiophene derivatives
WO2009004060A1 (de) * 2007-07-04 2009-01-08 Trin Pharma Gmbh Neue triazenverbindungen zur behandlung von krebs

Also Published As

Publication number Publication date
EP2686298B1 (de) 2018-05-09
JP2014515734A (ja) 2014-07-03
US9409859B2 (en) 2016-08-09
MX2013010401A (es) 2014-02-28
EA024381B1 (ru) 2016-09-30
MX346097B (es) 2017-03-07
IL228431A0 (en) 2013-12-31
EP2686298A1 (de) 2014-01-22
IL228431A (en) 2016-10-31
ES2683306T3 (es) 2018-09-26
EA201391335A1 (ru) 2014-01-30
US20140005149A1 (en) 2014-01-02
BR112013023316B1 (pt) 2021-12-14
SG193443A1 (en) 2013-10-30
CA2829998C (en) 2019-07-23
ZA201306794B (en) 2014-07-30
AU2012228755B2 (en) 2017-03-23
CN103492365A (zh) 2014-01-01
BR112013023316A2 (pt) 2016-12-06
AU2012228755A1 (en) 2013-09-12
WO2012122969A1 (de) 2012-09-20
CA2829998A1 (en) 2012-09-20

Similar Documents

Publication Publication Date Title
JPS63190857A (ja) 8−置換2−アミノテトラリン類
CZ285592A3 (en) Benzanilide derivatives, process of their preparation and pharmaceutical compositions containing them
NL8501124A (nl) Fenethanolamine-verbindingen, de bereiding daarvan, alsmede farmaceutische preparaten waarvan zij een component vormen.
JPH0112744B2 (enExample)
KR20220124228A (ko) 이소인돌린 유도체, 및 이의 제약 조성물 및 용도
KR20140011383A (ko) 치환된 디페닐 유도체
AU4442901A (en) Diphenyl ether compounds useful in therapy
JP6975705B2 (ja) 置換ベンゾトリアゾールフェノール
KR0130977B1 (ko) 항종양제로서 폴리아민 유도체
WO1998043943A1 (fr) Derives de 2-phenoxyaniline
CN109942462B (zh) 一种盐酸班布特罗的合成工艺
WO2004087628A1 (en) An amino alcohol ligand and its use in preparation of chiral proparglic tertiary alkohols and tertiary amines via enantioselective additon reaction
HK1187330A (en) Substituted diphenyl derivatives
CN105061267A (zh) 蓓萨罗丁的no供体n-羟基胍类衍生物及其制备方法
KR20060024784A (ko) 성기 종양의 표적 지향성 화학요법
UA67729C2 (uk) Біс(акридинкарбоксамід) та біс(феназинкарбоксамід) як протипухлинні агенти, спосіб їх одержання та фармацевтична композиція
CN112225673B (zh) 氨基康普立停衍生物及其应用
CN105073739B (zh) 用于制备吲唑衍生物的中间体及其制备方法
JP2003327574A (ja) ショウガオール類の製造方法および合成用中間体
JPS63239273A (ja) フエニルイミダゾ−ル誘導体
CN111499570B (zh) 一种av-45中间体的合成方法
HK40081791A (en) Isoindoline derivative, and pharmaceutical composition and use thereof
CN110713434A (zh) 具有抗癌活性化合物的中间体及其制备方法和应用
JPS6134428B2 (enExample)

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20131014

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20170206

Comment text: Request for Examination of Application

PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180228

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20180702

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180228

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I